Blog
Original analysis of GLP-1 and peptide pricing, evidence and regulation — written to be useful to someone deciding what to do, not to rank for a keyword.
Every article here starts from a specific claim we think is wrong, or a fact we think is being withheld. Brand prices collapsed and comparison sites did not update. ODT products have no trial evidence and cost more than the injection. "Microdosing" appeared industry-wide the month enforcement discretion ended. Some platforms resell brand drugs at eleven times the manufacturer price. Each of these is checkable, and each is checked here.
Brand GLP-1 prices collapsed. Most comparison sites still haven't
Zepbound fell to $299. Wegovy to $349. The oral tablet to $149. The price gap that justified compounded …
No trial has ever tested oral GLP-1 compounds. So why are they the
Compounded ODT tirzepatide and semaglutide have never been tested in a clinical trial — and they cost mo…
The $179 that is really $299: how introductory pricing works in GL
TrimRx advertises $179. MEDVi advertises $179. Both charge $299 from month two. Here is how first-month …
Why every GLP-1 provider suddenly sells 'microdosing'
The industry-wide pivot to microdosing tracks the end of FDA enforcement discretion almost exactly. That…
Eden sells Zepbound for $1,399. Lilly sells it for $299.
Some telehealth platforms resell brand-name GLP-1s at close to retail while the manufacturer sells the i…
Flat-rate vs dose-escalating GLP-1 pricing: a $3,000 difference
Some providers charge the same price at every dose. Others raise it as you titrate. Over a year, the gap…
Which GLP-1 providers charge no membership fee
Split billing makes programmes look cheaper than they are. Here is who charges a membership, who does no…
What a year of GLP-1 treatment actually costs
Monthly figures are how this is marketed. Annual totals are how it is experienced. Every provider, twelv…
Compounded or brand? The decision has changed
The compounded case rested on a price gap that has largely closed. Here is how to decide now.…
The cheap GLP-1 plan that caps your dose below the trial dose
Noom's $199 semaglutide is capped at 0.6mg. The STEP trials used 2.4mg. That is not a discount — it is a…
The LillyDirect 45-day rule that costs $250 if you are a week late
Zepbound's $449 maintenance rate holds only if you refill within 45 days of your last delivery. Miss it …
How to verify the pharmacy behind your GLP-1
The pharmacy matters more than the brand on the website. Seven questions, and what the answers tell you.…
Semaglutide sodium is not semaglutide
Some compounded products use semaglutide sodium or acetate. The FDA has said these are not the same acti…
455 adverse events, and the vial that causes most of them
The FDA has logged 455+ adverse events for compounded semaglutide and 320+ for tirzepatide. Dosing error…
What happens when you stop taking a GLP-1
Extension data found roughly two-thirds of lost weight returned within a year of stopping. That changes …
Tirzepatide vs semaglutide: what the only head-to-head trial found
SURMOUNT-5 put them against each other directly: −20.2% vs −13.7%. Here is the result, and the two cavea…
The GLP-1 pathway that costs $25 a month
If your plan covers Zepbound or Wegovy, a manufacturer savings card can bring it to roughly $25. Nothing…
Three ways peptide marketing overstates the evidence
Mouse-to-human transfer, biomarker-for-outcome substitution, and deficiency-to-enhancement transfer. Onc…
NAD+: real biology, thin clinical evidence
NAD+ decline with age is well-established cell biology. That supplementing it reverses ageing in humans …
Do not pay a subscription for a cheap generic
Both are FDA-approved and available as inexpensive generics. Compounded troches and 'proprietary blends'…
How to use this section
Everything in this section is built on the same two commitments, and it is worth stating them before you read anything else.
Every price carries an evidence status. Verified means we hold a dated capture of the provider's own page. Reported — pending verification means a provider or a third party reports it and we have not captured it ourselves. Evaluation in progress means verification is pending and we are not asserting the fact. We do not upgrade a price to Verified because another comparison site published it — sites in this category contradict each other routinely, and a figure repeated by three affiliate blogs is still one unverified figure.
Every clinical claim traces to a primary source. FDA labels and guidance for regulatory status; PubMed-indexed randomised trials for efficacy; ClinicalTrials.gov for trial design. Patient forums are never used as evidence of price, safety or efficacy, and animal research is never presented as proof of a human clinical effect.
The context that applies to everything here
Three facts sit underneath every page in this section, and if you take nothing else from it, take these.
Brand prices collapsed, and most comparison sites have not updated. Brand Zepbound is now $299-$449 through LillyDirect. Brand Wegovy is $349 through NovoCare, and the oral Wegovy tablet is $149. Foundayo, Lilly's approved oral GLP-1, starts at $149. With commercial insurance that covers them, either brand can be roughly $25 a month. Against that, a compounded programme priced above $299 is charging more than the FDA-approved drug.
The legal basis for compounding these molecules narrowed sharply in 2025. The FDA declared both shortages resolved and enforcement discretion ended for every class of compounder between February and May 2025. The surviving route requires a prescriber to document a clinical difference for the individual patient — which is what "personalized dosing" and "microdose" programmes are, as a matter of regulatory mechanics rather than clinical innovation.
The trial evidence applies to injections. Every efficacy figure in this field — SURMOUNT, STEP, SELECT — comes from an FDA-approved subcutaneous injection. None of it was collected on a compounded preparation, a microdose, or an orally disintegrating tablet. The evidence is strong exactly where it was gathered and silent everywhere else.
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.